Aptinyx Inc. Soared
Fri, Jan 17, 2020 at 05:30 PM
Aptinyx Inc. (APTX:NASDAQ) rocketted at $4.6, a gain of 27.8%. On Thu 16 Jan 20, APTX:NASDAQ hit a New 2-Week Intraday High of $3.9. The stock got featured on our News Catalysts scanner on Fri 17 Jan 20 at 05:21 PM in the 'INSIDER' category. From Thu 26 Dec 19, the stock recorded 42.86% Up Days and 33.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Aptinyx Inc. (APTX:NASDAQ)
Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.
Top 10 Gainers:
- iMedia Brands, Inc. (IMBI:NASDAQ), 42.22%
- CPI Card Group Inc. (PMTS:NASDAQ), 37.7%
- Platinum Group Metals Ltd. (PLG:NYSEMKT), 35.9%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 33.6%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Seneca Biopharma, Inc. (SNCA:NASDAQ), 28%
- Aptinyx Inc. (APTX:NASDAQ), 27.78%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 27.08%
- Kirkland's, Inc. (KIRK:NASDAQ), 25.98%
- Stage Stores, Inc. (SSI:NYSE), 21.99%